Long-term outcome of kidney function in patients with ANCA-associated vasculitis

被引:7
|
作者
Sachez-Alamo, Beatriz [1 ,2 ]
Moi, Laura [3 ]
Bajema, Ingeborg [4 ]
Berden, Annelies [5 ]
Flossmann, Oliver [6 ]
Hruskova, Zdenka [7 ]
Jayne, David [8 ]
Wester-Trejo, Maria [9 ]
Wallquist, Carin [10 ]
Westman, Kerstin [11 ]
机构
[1] Lund Univ, Dept Clin Sci Lund, Div Nephrol, Lund, Sweden
[2] Hosp Univ Sureste, Dept Nephrol, Madrid, Spain
[3] Univ Hosp Lausanne, Lausanne Univ, Dept Med, Div Immunol & Allergy, Lausanne, Switzerland
[4] Dept Pathol, Groningen, Netherlands
[5] Maasstad Hosp, Dept Rheumatol & Clin Immunol, Rotterdam, Netherlands
[6] Royal Berkshire Hosp, Dept Nephrol, Reading, England
[7] Charles Univ Prague, Gen Hosp Prague, Fac Med 1, Dept Nephrol, Prague, Czech Republic
[8] Univ Cambridge, Dept Med, Cambridge, England
[9] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands
[10] Skane Univ, Hosp Malmo, Dept Nephrol, Malmo, Sweden
[11] Lund Univ, Dept Clin Sci Lund, Div Nephrol, Lund, Sweden
关键词
ANCA-associated vasculitis; end-stage kidney disease; kidney histology scores; prognosis; transplantation; ANTIBODY-ASSOCIATED VASCULITIS; HISTOPATHOLOGICAL CLASSIFICATION; SPANISH REGISTRY; RENAL VASCULITIS; GLOMERULONEPHRITIS; BIOPSY; SURVIVAL; PROPOSAL; WEGENER; TRIALS;
D O I
10.1093/ndt/gfae018
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Kidney involvement is common in anti-neutrophil cytoplasm antibody-associated vasculitis (AAV) and the prognosis is determined by the severity of kidney damage. This study focused on long-term kidney outcomes, defining possible risk factors and comparing the performance of three different histological classifications to predict outcomes for patients with AAV. Methods. The dataset included 848 patients with newly diagnosed AAV who participated in seven randomized controlled trials (RCTs) (1995-2012). Follow-up information was obtained from questionnaires sent to the principal investigators of the original RCTs. Results. The cumulative incidence of end-stage kidney disease (ESKD) at 5 and 10 years was 17% and 22%, respectively. Patients who developed ESKD had reduced patient survival compared with those with preserved kidney function (hazard ratio 2.8, P < .001). Comparing patients with AAV and kidney involvement with a matched general population, patients with AAV had poor survival outcomes, even in early stages of chronic kidney disease. The main cause of death was infection followed by cardiovascular disease in patients developing ESKD and malignancy in those who did not. Some 34% of patients with initial need for dialysis recovered kidney function after treatment. Thirty-five out of 175 in need of kidney replacement therapy (KRT) during follow-up received a kidney transplant with good outcome; there was 86% patient survival at 10 years. In the subcohort of 214 patients with available kidney biopsies, three scoring systems were tested: the Berden classification, the Renal Risk Score and the Mayo Clinic Score. The scores highlighted the importance of normal glomeruli and severe glomerulosclerosis on kidney survival (P < .001 and P = .001, respectively). The Renal Risk Score demonstrated a moderate prediction of kidney survival (area under the curve 0.79; standard error 0.03, 95% confidence interval 0.71-0.83). Conclusions Early diagnosis of AAV is extremely important. Even milder forms of kidney involvement have an impact on the prognosis. Patients in need of KRT had the lowest survival rates, but kidney transplantation has shown favorable outcomes for eligible AAV patients. The three histologic scoring systems were all identified as independent prognostic factors for kidney outcome.
引用
收藏
页码:1483 / 1493
页数:11
相关论文
共 50 条
  • [1] Impact of different ANCA serotypes on the long-term outcome of ANCA-associated vasculitis patients
    Qi, Fumin
    Hao, Jian
    Wei, Wei
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [2] Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood
    Calatroni, Marta
    Consonni, Filippo
    Allinovi, Marco
    Bettiol, Alessandra
    Jawa, Natasha
    Fiasella, Susanna
    Curi, Dritan
    Abu-Rumeileh, Sarah
    Tomei, Leonardo
    Fortunato, Laura
    Gelain, Elena
    Gianfreda, Davide
    Oliva, Elena
    Jeannin, Guido
    Salviani, Chiara
    Emmi, Giacomo
    Bodria, Monica
    Sinico, Renato
    Moroni, Gabriella
    Ramirez, Giuseppe A.
    Bozzolo, Enrica
    Tombetti, Enrico
    Monti, Sara
    Bracaglia, Claudia
    Marucci, Giulia
    Pastore, Serena
    Esposito, Pasquale
    Catanoso, Maria
    Crapella, Barbara
    Montini, Giovanni
    Roperto, Rosa
    Materassi, Marco
    Rossi, Giovanni
    Badalamenti, Salvatore
    Yeung, Rae
    Romagnani, Paola
    Ghiggeri, Gian Marco
    Noone, Damien
    Vaglio, Augusto
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (07): : 1043 - 1051
  • [3] Long-term patient survival in ANCA-associated vasculitis
    Flossmann, Oliver
    Berden, Annelies
    de Groot, Kirsten
    Hagen, Chris
    Harper, Lorraine
    Heijl, Caroline
    Hoglund, Peter
    Jayne, David
    Luqmani, Raashid
    Mahr, Alfred
    Mukhtyar, Chetan
    Pusey, Charles
    Rasmussen, Niels
    Stegeman, Coen
    Walsh, Michael
    Westman, Kerstin
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (03) : 488 - 494
  • [4] Long-term outcomes in elderly patients with ANCA-associated vasculitis
    McGovern, Dominic
    Williams, Sam P.
    Parsons, Katrina
    Farrah, Tariq E.
    Gallacher, Peter J.
    Miller-Hodges, Eve
    Kluth, David C.
    Hunter, Robert W.
    Dhaun, Neeraj
    RHEUMATOLOGY, 2020, 59 (05) : 1076 - 1083
  • [5] Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis
    Sanchez alamo, Beatriz
    Moi, Laura
    Bajema, Ingeborg
    Faurschou, Mikkel
    Flossmann, Oliver
    Hauser, Thomas
    Hruskova, Zdenka
    Jayne, David
    Luqmani, Raashid
    Mahr, Alfred
    akesson, Anna
    Westman, Kerstin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (07) : 1655 - 1665
  • [6] Outcome and Treatment of Elderly Patients with ANCA-Associated Vasculitis
    Weiner, Maria
    Goh, Su Mein
    Mohammad, Aladdin J.
    Hruskova, Zdenka
    Tanna, Anisha
    Bruchfeld, Annette
    Selga, Daina
    Chocova, Zdenka
    Westman, Kerstin
    Eriksson, Per
    Pusey, Charles D.
    Tesar, Vladimir
    Salama, Alan D.
    Segelmark, Marten
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (07): : 1128 - 1135
  • [7] Long-term safety and efficacy of rituximab in 7 Japanese patients with ANCA-associated vasculitis
    Nagafuchi, Hiroko
    Atsumi, Tatsuya
    Hatta, Kazuhiro
    Muso, Eri
    Takeno, Mitsuhiro
    Yamada, Hidehiro
    Ozaki, Shoichi
    MODERN RHEUMATOLOGY, 2015, 25 (04) : 603 - 608
  • [8] Complications of long-term therapy for ANCA-associated systemic vasculitis
    Wall, Nadezhda
    Harper, Lorraine
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (09) : 523 - 532
  • [9] Renal outcome of kidney-transplantation in Korean recipients with ANCA-associated vasculitis
    Park, E. S.
    Ahn, S. S.
    Jung, S. M.
    Song, J. J.
    Park, Y. -B.
    Lee, S. -W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : S115 - S120
  • [10] PULMONARY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Dieterich, Johannes
    Hellmich, Bernhard
    Mahrhold, Juliane
    Feng, You-Shan
    El Rai, Abdallah
    Nessyt, Felix
    Specks, Ulrich
    Hetzel, Juergen
    Loeffler, Christian
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2024, 41 (02)